{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:08:47Z","timestamp":1795172927161,"version":"4.10.3"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.compbiomed.2022.106049","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T02:02:37Z","timestamp":1662602557000},"page":"106049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host"],"prefix":"10.1016","volume":"149","author":[{"given":"Shivangi","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-1338","authenticated-orcid":false,"given":"Ekta","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-5258","authenticated-orcid":false,"given":"Rajeev","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afifa","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswarappa S.","family":"Byadgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-542X","authenticated-orcid":false,"given":"Ashvanee Kumar","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwambhar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameshwar Nath","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Atri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2022.106049_bib1","unstructured":"W.H. Organization, WHO Coronavirus Disease (COVID-19) Dashboard, covid19.who.int."},{"key":"10.1016\/j.compbiomed.2022.106049_bib2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib3","article-title":"A pathological report of three COVID-19 cases by minimally invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua bing li xue za zhi= Chinese journal of pathology"},{"key":"10.1016\/j.compbiomed.2022.106049_bib4","first-page":"1","article-title":"Single-cell transcriptome analysis reveals the role of pancreatic secretome in COVID-19 associated multi-organ dysfunctions","author":"Pathak","year":"2022","journal-title":"Interdiscipl. Sci. Comput. Life Sci."},{"key":"10.1016\/j.compbiomed.2022.106049_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4014\/jmb.2003.03011","article-title":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)","volume":"30","author":"Ahn","year":"2020","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41577-021-00556-5","article-title":"Will SARS-CoV-2 variants of concern affect the promise of vaccines?","volume":"21","author":"Gupta","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41564-021-01053-0","article-title":"Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario","volume":"7","author":"Nasreen","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"6","key":"10.1016\/j.compbiomed.2022.106049_bib8","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS\u2010CoV\u20102 Omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"issue":"14","key":"10.1016\/j.compbiomed.2022.106049_bib9","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa2119658","article-title":"Population immunity and Covid-19 severity with Omicron variant in South Africa","volume":"386","author":"Madhi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111518","article-title":"Potential therapeutic agents to COVID-19: an update review on antiviral therapy, immunotherapy, and cell therapy","volume":"138","author":"Mirtaleb","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2022.106049_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/pharmaceutics13030302","article-title":"Drug repurposing in the COVID-19 era: insights from case studies showing pharmaceutical peculiarities","volume":"13","author":"Gatti","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.compbiomed.2022.106049_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109480","article-title":"Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles","volume":"343","author":"Rabie","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.compbiomed.2022.106049_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107831","article-title":"Cyanorona-20: the first potent anti-SARS-CoV-2 agent","volume":"98","author":"Rabie","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.compbiomed.2022.106049_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jtcme.2021.05.005","article-title":"In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors","volume":"12","author":"Singh","year":"2022","journal-title":"J. Tradit., Complementary Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib16","article-title":"RNA\u2013RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection","volume":"23","author":"Zhang","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2022.106049_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.104117","article-title":"Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs","volume":"128","author":"Bhardwaj","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-08320-y","article-title":"In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs","volume":"12","author":"Chan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.106049_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/v13020305","article-title":"Structure-Based identification of natural products as SARS-CoV-2 Mpro antagonist from Echinacea angustifolia using computational approaches","volume":"13","author":"Bharadwaj","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.compbiomed.2022.106049_bib20","first-page":"1","article-title":"The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro","author":"Ngwe Tun","year":"2022","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131106","article-title":"Discovery of Taroxaz-104: the first potent antidote of SARS-CoV-2 VOC-202012\/01 strain","volume":"1246","author":"Rabie","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiomed.2022.106049_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib23","first-page":"433","article-title":"New potential inhibitors of coronaviral main protease (CoV-Mpro): strychnine bush, pineapple, and ginger could be natural enemies of COVID-19","volume":"9","author":"Rabie","year":"2022","journal-title":"Int. J. Network. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021579118","article-title":"Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection","volume":"118","author":"Jan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiomed.2022.106049_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jtcme.2021.09.001","article-title":"The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins","volume":"12","author":"Singh","year":"2022","journal-title":"J. Tradit., Complementary Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib26","first-page":"1","article-title":"Coronavirus genome structure and replication","volume":"287","author":"Brian","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib28","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1\u2010helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.compbiomed.2022.106049_bib29","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiomed.2022.106049_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for anti\u2013COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.compbiomed.2022.106049_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.aivir.2016.08.008","article-title":"The nonstructural proteins directing coronavirus RNA synthesis and processing","volume":"96","author":"Snijder","year":"2016","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4161\/rna.8.2.15196","article-title":"Nidovirus ribonucleases: structures and functions in viral replication","volume":"8","author":"Ulferts","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","article-title":"Virus-encoded proteinases and proteolytic processing in the Nidovirales","volume":"81","author":"Ziebuhr","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib34","first-page":"341","article-title":"The nsp9 replicase protein of SARS-coronavirus","volume":"12","author":"Sutton","year":"2004","journal-title":"Struct. Funct. Insights"},{"key":"10.1016\/j.compbiomed.2022.106049_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101258","article-title":"Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9","volume":"23","author":"Littler","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.compbiomed.2022.106049_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12250-020-00242-1","article-title":"SARS-coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can be inhibited by bismuth salts","volume":"35","author":"Shu","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.compbiomed.2022.106049_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12250-016-3726-4","article-title":"Molecular mechanisms of coronavirus RNA capping and methylation","volume":"31","author":"Chen","year":"2016","journal-title":"Virol. Sin."},{"key":"10.1016\/j.compbiomed.2022.106049_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17495-9","article-title":"Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin","volume":"11","author":"Krafcikova","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib40","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105938","article-title":"Structures of the SARS\u2010CoV\u20102 nucleocapsid and their perspectives for drug design","volume":"39","author":"Peng","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.compbiomed.2022.106049_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.foodchem.2015.10.096","article-title":"Phenolic content, antioxidant activity and effective compounds of kumquat extracted by different solvents","volume":"197","author":"Lou","year":"2016","journal-title":"Food Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/joa.joa_231_20","article-title":"Management approach to Covid-19 associated upper respiratory tract infection in Ayurveda: a review study","volume":"14","author":"Pamnani","year":"2020","journal-title":"J. Ayurveda"},{"key":"10.1016\/j.compbiomed.2022.106049_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/jacr.jacr_57_20","article-title":"Three case reports of moderate COVID-19 infection managed through Ayurvedic approach","volume":"3","author":"Jyothi","year":"2020","journal-title":"J. Ayurveda Case Rep"},{"key":"10.1016\/j.compbiomed.2022.106049_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/joa.joa_140_20","article-title":"Ayurveda prophylaxis and intervention for COVID-19 Pandemic","volume":"14","author":"Chambyal","year":"2020","journal-title":"J. Ayurveda"},{"key":"10.1016\/j.compbiomed.2022.106049_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/JISM.JISM_54_20","article-title":"Ayurveda interpretation, diagnostic, and probable management of COVID-19 pandemic","volume":"8","author":"Kumar","year":"2020","journal-title":"J. Ind. Sys. Med"},{"key":"10.1016\/j.compbiomed.2022.106049_bib46","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.3390\/molecules26196068","article-title":"Natural polyphenols inhibit the dimerization of the SARS-CoV-2 main protease: the case of fortunellin and its structural analogs","volume":"26","author":"Panagiotopoulos","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2022.106049_bib47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1248\/bpb.23.1072","article-title":"Inhibitory activity of flavonoids and tannins against HIV-1 protease","volume":"23","author":"Xu","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.compbiomed.2022.106049_bib48","first-page":"7","article-title":"Antibacterial activity of Ficus lyrata-An in vitro study","volume":"8","author":"Rizvi","year":"2010","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib49","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1039\/C7CP07869B","article-title":"Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder","volume":"20","author":"Xue","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2022.106049_bib50","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/acschemneuro.8b00059","article-title":"Exploring the binding mechanism of metabotropic glutamate receptor 5 negative allosteric modulators in clinical trials by molecular dynamics simulations","volume":"9","author":"Fu","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2022.106049_bib51","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1021\/acsomega.1c05998","article-title":"Potent inhibitory activities of the adenosine analogue cordycepin on SARS-CoV-2 replication","volume":"7","author":"Rabie","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2022.106049_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib53","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib54","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2022.106049_bib56","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2. 0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2022.106049_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib58","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"Software"},{"key":"10.1016\/j.compbiomed.2022.106049_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.compbiomed.2022.106049_bib61","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib62","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2022.106049_bib63","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib64","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2022.106049_bib65","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.compbiomed.2022.106049_bib66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08927028808080941","article-title":"A leap-frog algorithm for stochastic dynamics","volume":"1","author":"Van Gunsteren","year":"1988","journal-title":"Mol. Simulat."},{"key":"10.1016\/j.compbiomed.2022.106049_bib67","series-title":"XMGRACE, 5.1. 19","author":"Turner","year":"2005"},{"key":"10.1016\/j.compbiomed.2022.106049_bib68","series-title":"Amber 2021: Reference Manual","author":"Case","year":"2021"},{"key":"10.1016\/j.compbiomed.2022.106049_bib69","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2022.106049_bib70","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA. py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2022.106049_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.compbiomed.2022.106049_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib73","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib75","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib76","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib77","series-title":"Data Analysis, Ggplot2","first-page":"189","author":"Wickham","year":"2016"},{"key":"10.1016\/j.compbiomed.2022.106049_bib78","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape StringApp: network analysis and visualization of proteomics data","volume":"18","author":"Doncheva","year":"2019","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.compbiomed.2022.106049_bib79","first-page":"1","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL M pro active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib82","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1039\/D0SC02823A","article-title":"Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 M pro by QM\/MM computational methods","volume":"11","author":"\u015awiderek","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.compbiomed.2022.106049_bib83","first-page":"23","article-title":"Crystal structure of the SARS-CoV-2 non-structural protein 9","author":"Littler","year":"2020","journal-title":"Nsp9, iScience"},{"key":"10.1016\/j.compbiomed.2022.106049_bib84","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/d41586-021-03552-w","article-title":"Heavily mutated Omicron variant puts scientists on alert","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2022.106049_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107930","article-title":"Drug repurposing for COVID-19: approaches, challenges and promising candidates","volume":"228","author":"Ng","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.compbiomed.2022.106049_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102234","article-title":"Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts\u2013What is known so far?","volume":"45","author":"Poudel","year":"2022","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.compbiomed.2022.106049_bib87","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1039\/D0NJ03708G","article-title":"Two antioxidant 2, 5-disubstituted-1, 3, 4-oxadiazoles (CoViTris2020 and ChloViD2020): successful repurposing against COVID-19 as the first potent multitarget anti-SARS-CoV-2 drugs","volume":"45","author":"Rabie","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib88","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s11030-020-10169-0","article-title":"CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy","volume":"25","author":"Rabie","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.compbiomed.2022.106049_bib89","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbrc.2017.06.076","article-title":"Fortunellin protects against high fructose-induced diabetic heart injury in mice by suppressing inflammation and oxidative stress via AMPK\/Nrf-2 pathway regulation","volume":"490","author":"Zhao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib90","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fimmu.2018.00083","article-title":"Fortunellin-Induced modulation of phosphatase and tensin homolog by MicroRNA-374a decreases inflammation and maintains intestinal barrier function in colitis","volume":"9","author":"Xiong","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib91","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.compbiomed.2022.106049_bib92","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1038\/s41598-021-86471-0","article-title":"Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity","volume":"11","author":"Weng","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.106049_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74099-5","article-title":"Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation","volume":"10","author":"Komatsu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.106049_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77794-5","article-title":"Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"10","author":"Shitrit","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.106049_bib95","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for anti\u2013COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"J Science advances"},{"key":"10.1016\/j.compbiomed.2022.106049_bib96","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"De Wit","year":"2020","journal-title":"J Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.compbiomed.2022.106049_bib97","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"J. Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2022.106049_bib98","first-page":"1","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"J. Nat. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib99","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/cells10051052","article-title":"Remdesivir and ledipasvir among the FDA-approved antiviral drugs have potential to inhibit SARS-CoV-2 replication","volume":"10","author":"Pirzada","year":"2021","journal-title":"J. Cell."},{"key":"10.1016\/j.compbiomed.2022.106049_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-01566-0","article-title":"Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2","volume":"4","author":"Kim","year":"2021","journal-title":"J Communications biology"},{"key":"10.1016\/j.compbiomed.2022.106049_bib101","first-page":"1","article-title":"Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics","volume":"12","author":"Pillon","year":"2021","journal-title":"J. Nat. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib102","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1039\/D0NJ04909C","article-title":"Targeting Nsp9 as an anti-SARS-CoV-2 strategy","volume":"45","author":"Farias","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib103","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jmb.2008.07.071","article-title":"Variable oligomerization modes in coronavirus non-structural protein 9","volume":"383","author":"Ponnusamy","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101362","article-title":"A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein","volume":"297","author":"Littler","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib105","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1021\/acsomega.1c07186","article-title":"Binding studies of the prodrug HAO472 to SARS-Cov-2 Nsp9 and variants","volume":"7","author":"Liu","year":"2022","journal-title":"J ACS omega"},{"key":"10.1016\/j.compbiomed.2022.106049_bib106","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11030-021-10251-1","article-title":"Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study","volume":"26","author":"Vivek-Ananth","year":"2022","journal-title":"J Molecular diversity"},{"key":"10.1016\/j.compbiomed.2022.106049_bib107","article-title":"Modelling, the SARS-CoV-2 helicase as a target for antiviral therapy: identification of potential small molecule inhibitors by in silico modelling","volume":"114","author":"Pitsillou","year":"2022","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.compbiomed.2022.106049_bib108","article-title":"medicine, in silico evidence of beauvericin antiviral activity against SARS-CoV-2","volume":"141","author":"Al Khoury","year":"2022","journal-title":"J. Comp.Biol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib109","article-title":"Toward wide-spectrum antivirals against coronaviruses: molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors","volume":"8","author":"Perez-Lemus","year":"2022","journal-title":"J Science advances"},{"key":"10.1016\/j.compbiomed.2022.106049_bib110","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1021\/acs.jpclett.0c02421","article-title":"Discovery of COVID-19 inhibitors targeting the SARS-CoV-2 Nsp13 helicase","volume":"11","author":"White","year":"2020","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.compbiomed.2022.106049_bib111","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14756366.2021.2022659","article-title":"Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors","volume":"37","author":"El Hassab","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib112","first-page":"1","article-title":"Structural basis of RNA cap modification by SARS-CoV-2","volume":"11","author":"Viswanathan","year":"2020","journal-title":"J. Nat. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib113","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/v13040538","article-title":"NSP16 2\u2032-O-MTase in coronavirus pathogenesis: possible prevention and treatments strategies","volume":"13","author":"Chang","year":"2021","journal-title":"J Viruses"},{"key":"10.1016\/j.compbiomed.2022.106049_bib114","article-title":"High-resolution structures of the SARS-CoV-2 2\u2032-O-methyltransferase reveal strategies for structure-based inhibitor design","volume":"13","author":"Rosas-Lemus","year":"2020","journal-title":"J Science signaling"},{"key":"10.1016\/j.compbiomed.2022.106049_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2021.138618","article-title":"In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex","volume":"774","author":"Liang","year":"2021","journal-title":"J Chemical Physics Letters"},{"key":"10.1016\/j.compbiomed.2022.106049_bib116","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1080\/07391102.2020.1779133","article-title":"Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study","volume":"39","author":"Tazikeh-Lemeski","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2022.106049_bib117","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.compbiomed.2022.106049_bib118","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00203-020-01998-6","article-title":"SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study","volume":"203","author":"Khan","year":"2021","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib119","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3390\/molecules26092593","article-title":"Antiviral properties of the NSAID drug naproxen targeting the nucleoprotein of SARS-CoV-2 coronavirus","volume":"26","author":"Terrier","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2022.106049_bib120","article-title":"Targeting the N-terminus domain of the coronavirus nucleocapsid protein induces abnormal oligomerization via allosteric modulation","volume":"9","author":"Hsu","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.compbiomed.2022.106049_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113966","article-title":"Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2","volume":"227","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2022.106049_bib122","series-title":"2.05 Angstrom Resolution Crystal Structure of C-Terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2. 2020","author":"Minasov","year":"2020"},{"key":"10.1016\/j.compbiomed.2022.106049_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.798","article-title":"p\u2010cymene impairs SARS\u2010CoV\u20102 and Influenza A (H1N1) viral replication: in silico predicted interaction with SARS\u2010CoV\u20102 nucleocapsid protein and H1N1 nucleoprotein","volume":"9","author":"Panagiotopoulos","year":"2021","journal-title":"Pharmacology research & perspectives"},{"key":"10.1016\/j.compbiomed.2022.106049_bib124","first-page":"1","article-title":"In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2","author":"Rani","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2022.106049_bib125","first-page":"1","article-title":"GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2022.106049_bib126","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virusres.2014.05.011","article-title":"Retrospective on the all-in-one retroviral nucleocapsid protein","volume":"193","author":"Darlix","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib127","first-page":"1321","article-title":"Increased serum levels of soluble TNF-\u03b1 receptor is associated with ICU mortality in COVID-19 patients","author":"Mortaz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2022.106049_bib128","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib129","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.compbiomed.2022.106049_bib130","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.compbiomed.2022.106049_bib131","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1152\/physrev.00046.2020","article-title":"CD38 in the age of COVID-19: a medical perspective","volume":"101","author":"Horenstein","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.compbiomed.2022.106049_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.4","article-title":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2","volume":"1","author":"Yeung","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.compbiomed.2022.106049_bib133","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1007\/s11033-020-05831-7","article-title":"Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2","volume":"47","author":"Meini","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.compbiomed.2022.106049_bib134","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.2147\/IDR.S329004","article-title":"Impact of high serum levels of MMP-7, MMP-9, TGF-\u03b2 and PDGF macrophage activation markers on severity of COVID-19 in obese-diabetic patients","volume":"14","author":"El-Din","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.compbiomed.2022.106049_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154374","article-title":"Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity","volume":"112","author":"Moin","year":"2020","journal-title":"Metab. Clin. Exp."},{"issue":"1","key":"10.1016\/j.compbiomed.2022.106049_bib136","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/jiab167","article-title":"Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19","volume":"224","author":"Syed","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.compbiomed.2022.106049_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.703868","article-title":"Extracellular matrix enzymes and immune cell biology","volume":"8","author":"McMahon","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.compbiomed.2022.106049_bib138","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ddr.21794","article-title":"Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy","volume":"82","author":"Prasher","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.compbiomed.2022.106049_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-4-55","article-title":"Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection","volume":"4","author":"Raaben","year":"2007","journal-title":"Virol. J."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252200765X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252200765X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T19:54:59Z","timestamp":1757879699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001048252200765X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":139,"alternative-id":["S001048252200765X"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106049","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2022-djv9k","asserted-by":"object"}]},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106049"}}